ArticlePDF Available

Dietary adenosine supplementation improves placental angiogenesis in IUGR piglets by up-regulating adenosine A2a receptor

Authors:

Abstract and Figures

Abnormal placental angiogenesis is associated with the occurrence of intrauterine growth restriction (IUGR) in piglets, and effective treatment strategies against this occurrence remain to be explored. Adenosine has been reported to play an important role in angiogenesis, but its role in placental angiogenesis is still unknown. Here, we investigated the effect of dietary adenosine supplementation on IUGR occurrence in piglets by analyzing the role of adenosine in placental angiogenesis for Normal and IUGR piglets. Specifically, 88 sows were allotted to 2 treatments (n = 44) and fed a basal diet supplemented with 0% or 0.1% of adenosine from day 65 of gestation until farrowing, followed by collecting the placental samples of Normal and IUGR piglets, and recording their characteristics. The results showed that adenosine supplementation increased the mean birth weight of piglets (P < 0.05) and placental efficiency (P < 0.05), while decreasing the IUGR piglet rate (P < 0.05). Expectedly, the placenta for IUGR neonates showed a down-regulated vascular density (P < 0.05) and angiogenesis as evidenced by the expression level of vascular cell adhesion molecule-1 (VCAM1) (P < 0.05). Notably, dietary adenosine supplementation promoted angiogenesis (P < 0.05) both in the Normal and IUGR placenta. More importantly, the expression level of adenosine A2a receptor (ADORA2A) was lower (P < 0.05) in the IUGR placenta than in Normal placenta, whereas adenosine treatment could significantly increase ADORA2A expression, and also had an interaction effect between factors IUGR and Ado. Collectively, placentae for IUGR piglets showed impaired angiogenesis and down-regulated expression level of ADORA2A, while dietary adenosine supplementation could activate ADORA2A expression, improve the placental angiogenesis, and ultimately decrease the occurrence of IUGR in piglets.
Content may be subject to copyright.
Original Research Article
Dietary adenosine supplementation improves placental angiogenesis
in IUGR piglets by up-regulating adenosine A2a receptor
Zifang Wu
a
,
1
, Jiawei Nie
a
,
1
, Deyuan Wu
a
, Shuangbo Huang
a
, Jianzhao Chen
a
,
Huajin Liang
a
, Xiangyu Hao
a
, Li Feng
a
, Hefeng Luo
b
,
*
, Chengquan Tan
a
,
*
a
Guangdong Provincial Key Laboratory of Animal Nutrition Control, National Engineering Research Center for Breeding Swine Industry, Institute of
Subtropical Animal Nutrition and Feed, College of Animal Science, South China Agricultural University, Guangzhou, Guangdong 510642, China
b
Dekon Food and Agriculture Group, Chengdu, China
article info
Article history:
Received 28 April 2022
Received in revised form
9 December 2022
Accepted 15 February 2023
Available online 22 February 2023
Keywords:
Angiogenesis
IUGR
Placenta
Adenosine
ADORA2A
abstract
Abnormal placental angiogenesis is associated with the occurrence of intrauterine growth restriction
(IUGR) in piglets, and effective treatment strategies against this occurrence remain to be explored.
Adenosine has been reported to play an important role in angiogenesis, but its role in placental angio-
genesis is still unknown. Here, we investigated the effect of dietary adenosine supplementation on IUGR
occurrence in piglets by analyzing the role of adenosine in placental angiogenesis for Normal and IUGR
piglets. Specically, 88 sows were allotted to 2 treatments (n¼44) and fed a basal diet supplemented
with 0% or 0.1% of adenosine from day 65 of gestation until farrowing, followed by collecting the
placental samples of Normal and IUGR piglets, and recording their characteristics. The results showed
that adenosine supplementation increased the mean birth weight of piglets (P<0.05) and placental
efciency (P<0.05), while decreasing the IUGR piglet rate (P<0.05). Expectedly, the placenta for IUGR
neonates showed a down-regulated vascular density (P<0.05) and angiogenesis as evidenced by the
expression level of vascular cell adhesion molecule-1 (VCAM1) (P<0.05). Notably, dietary adenosine
supplementation promoted angiogenesis (P<0.05) both in the Normal and IUGR placenta. More
importantly, the expression level of adenosine A2a receptor (ADORA2A) was lower (P<0.05) in the IUGR
placenta than in Normal placenta, whereas adenosine treatment could signicantly increase ADORA2A
expression, and also had an interaction effect between factors IUGR and Ado. Collectively, placentae for
IUGR piglets showed impaired angiogenesis and down-regulated expression level of ADORA2A, while
dietary adenosine supplementation could activate ADORA2A expression, improve the placental angio-
genesis, and ultimately decrease the occurrence of IUGR in piglets.
©2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
1. Introduction
As a complication of pregnancy, intrauterine growth restriction
(IUGR) can cause a low birth weight (LBW) for neonates, and about
15% to 25% of piglets were reported to suffer from IUGR in pig
production (Freking et al., 2016). IUGR can bring a series of adverse
consequences to piglets, such as a higher rate of morbidity and
mortality, slower growth rate, as well as abnormal organ devel-
opment (Oksbjerg et al., 2013;Wu et al., 2006), suggesting a
benecial effect of reducing IUGR rate on the reproductive ef-
ciency of sows. However, the mechanism underlying IUGR occur-
rence is still largely unclear.
It is essential for the placenta to efciently transfer oxygen and
nutrients from the mother to the fetus to maintain normal fetal
*Corresponding authors.
E-mail addresses: sixres@126.com (H. Luo), tanchengquan@scau.edu.cn
(C. Tan).
1
These authors contributed equally to this work.
Peer review under responsibility of Chinese Association of Animal Science and
Veterinary Medicine.
Production and Hosting by Elsevier on behalf of KeAi
Contents lists available at ScienceDirect
Animal Nutrition
journal homepage: http://www.keaipublishing.com/en/journals/aninu/
https://doi.org/10.1016/j.aninu.2023.02.003
2405-6545/©2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Animal Nutrition 13 (2023) 282e288
growth, and the blood vessels in the placenta play an important
role in the exchange of maternalefetal material (Reynolds et al.,
2006;Sun et al., 2020;Zhang et al., 2022). Previous studies
revealed abnormal angiogenesis in LBW placenta (Hu et al., 2021;
Huang et al., 2021a), implying that improving angiogenesis in the
placenta might decrease IUGR occurrence. As an endogenous pu-
rine nucleoside, adenosine exerts its biological effects by activating
its 4 adenosine receptor subtypes, including adenosine A1 receptor
(ADORA1); adenosine A2a receptor (ADORA2A); adenosine A2b
receptor (ADORA2B) and adenosine A3 receptor (ADORA3) (Salsoso
et al., 2017). Previous studies have conrmed the promoting role of
adenosine in biological and pathological angiogenesis (Antonioli
et al., 2021;Troncoso et al., 2020;Valls et al., 2021). Additionally,
adenosine was reported to activate ADORA2A to potentiate angio-
genesis by regulating the levels of angiogenesis factors including
vascular endothelial growth factor (VEGF) and hypoxia inducible
factor-1
a
(HIF-1
a
)(Escudero et al., 2013;Fernandez et al., 2012;Liu
et al., 2017). However, the effect of adenosine on placental angio-
genesis remains to be further investigated.
In this study, adenosine was assumed to alleviate IUGR occur-
rence by enhancing placental angiogenesis, and this hypothesis was
tested by analyzing the effects of adenosine on the occurrence of
IUGR piglets and comparing the angiogenesis and the expression of
adenosine receptors in placentae for Normal and IUGR piglets.
2. Materials and methods
2.1. Animal ethics statement
All animal experimental design and procedures presented in
this study were approved by the Animal Care and Use Committee of
the Institute of Subtropical Agriculture, Chinese Academy of Sci-
ence, and performed according to the Guidelines for Care and Use
of Laboratory Animals of South China Agriculture University
(Guangzhou, China).
2.2. Animals and experimental design
The sows used in this study were obtained from Jiangxi Wan-
nian Xinxing Agro-pastoral Co., Ltd., China. A total of 88
Duroc Landrace Yorkshire sows were divided into 2 dietary
treatment groups, each sow as a replicate of a completely ran-
domized design, based on the body weight at day 65 of gestation
(n¼44 per treatment). From day 65 of gestation to farrowing, the
control group (Con) sows were fed a basal gestation diet without
adenosine supplementation, while the adenosine group (Ado) sows
were fed a basal diet with 0.1% adenosine supplementation.
Adenosine was from Hangzhou Kaipeng Biotechnology Co., Ltd.,
Hangzhou, China, purity (HPLC) 98.0%. Both diets were formu-
lated to meet the National Research Council (NRC, 2012) nutritional
standards for gestational sows. The composition of the diet is
shown in Supplementary Table S1. The feed intake of the sows is
shown in Supplementary Table S2.
2.3. Data collection and sampling
After farrowing, the number and weight of piglets born were
recorded. The IUGR rate was calculated as previously described
(Aditya et al., 2016). Briey, IUGR piglets were dened as piglets
with a birth weight of 2 standard deviations lower than the mean
birth weight of the Con group piglets. When piglets were born, the
umbilical cord was immediately tied with a silk line (labeled with a
number tag to indicate the birth order of the piglet), and each piglet
was marked with a numbered tag to match the placenta. The
newborn piglet birth weight and numerical order were recorded,
the placenta weight was also recorded after placental expulsion.
Then, approximately 10 g of the placenta (3 to 4 cm from the cord
insertion point) was collected and snap-frozen immediately in
liquid nitrogen, and another fresh placental tissue was collected
and xed in 4% paraformaldehyde immediately. The placental ef-
ciency was calculated by dividing piglet weight by placental
weight (Wilson et al.,1999). The average birth weight of 441 piglets
in the Con group in this study was 1.37 ±0.15 kg (mean ±SD), and
the placental samples were divided into 2 groups according to
piglet birth weight: <1.07 kg (IUGR) and 1.37 to 1.52 kg (Normal).
Six sows were randomly selected from each group, and each sow
was randomized to provide 1 placenta of Normal fetal (piglet with
birth weight 1.37 to 1.52 kg) and 1 placenta of IUGR fetal (piglet
with birth weight <1.07 kg) for following analysis.
2.4. Placental vascular density
Six sows were selected from each group, and 2 placental samples
of each sow were analyzed, including 1 Normal and 1 IUGR placental
sample. By image analysis, the number of blood vessels was deter-
mined by estimating the mean value of 3 slices of 1 placenta. Briey,
fresh placental tissues xed in 4% paraformaldehyde were parafn-
embedded and sectioned at 5
m
m thickness, then stained with he-
matoxylin and eosin (H&E). The areas occupied by placental tissues
and the placental vessels in these areas were traced with a projec-
ting microscope (Olympus CX41, Japan). For each of the 5
m
m sec-
tions, the total number of vessels in the placental stromal areas were
determined and then corrected for the measured total placental
stromal areas (per unit area as mm
2
).
2.5. Quantitative real-time RT-PCR analysis
Total RNA from placental tissues was extracted with the reagent
box of a Tissue RNA Purication Kit (EZBioscience, Suzhou, China)
as instructed by the manufacturer. The concentration of RNA was
quantied using a NanoDrop-2000 (Thermo Fisher, USA). After
reverse transcription using a Color Reverse Transcription Kit
(EZBioscience, Suzhou, China), qRT-PCR was conducted using SYBR
Green on a QuantStudio 6 RealTime PCR System (Thermo Fisher,
USA) under the conditions of denaturation at 95
C for 10 min,
amplication at 95
C for 15 s and 60
C for 1 min for 40 cycles. Each
target gene was individually normalized to the reference gene 18S
rRNA by using the quantication method of 2
DD
ct
. Primers used in
this study are shown in Supplemental Table S3.
2.6. Western blotting
Total proteins were extracted from placental tissues using a
protein extraction kit (Beyotime, Beijing, China) as informed by the
manufacturer. Briey, 10
m
g of protein was loaded and separated by
SDS-PAGE gel electrophoresis, and then the protein was transferred
onto a polyvinylidene diuoride membrane (Merck Millipore). Af-
ter blocking with TBST buffer containing 5% milk, the blots were
then incubated overnight at 4
C with each of the following primary
antibodies: angiogenin (Ang) (ab95389, abcam, 1:1000), ADORA1
(ab82477, abcam, 1:1000), ADORA2A (ab3461, abcam, 1:1000),
ADORA2B (ab222901, abcam, 1:1000), ADORA3 (ab197350, abcam,
1:1000), vascular endothelial growth factor A (VEGF-A) (19003-1-
AP, Proteintech, USA, 1:1000), Akt (9272, CST, 1:1000), p-Akt
(4060, CST, 1:1000), signal transducer and activator of
transcription-3 (Stat3) (ab76315, Abcam, USA, 1:1500), p-Stat3
(ab68153, Abcam, USA, 1:1500), vascular cell adhesion molecule-1
(VCAM1) (ab134047, abcam, 1:1000), and
b
-actin (4970, CST, USA,
1:1000). Subsequently, the membranes were incubated with
appropriate HRP-conjugated anti-rabbit IgG secondary antibody
Z. Wu, J. Nie, D. Wu et al. Animal Nutrition 13 (2023) 282e288
283
(AS014, Abclonal, China, 1:5000). Images were captured using the
ChemiDoc MP system (Bio-Rad, Hercules, CA, USA), and band
densities were quantied using Image Lab soft-ware (Bio-Rad,
Hercules, CA, USA) and then normalized to
b
-actin content.
2.7. Immunouorescence
Placental tissues immobilized in 4% paraformaldehyde were
embedded in parafn and sectioned at 5
m
m thickness for platelet
endothelial cell adhesion molecule-1 (CD31) and ADORA2A
immunouorescence. Slides were visualized under a uorescent
microscope (Nikon Eclipse C1, Tokyo, Japan) and quantied by
ImageJ software.
2.8. Statistical analysis
All data were presented with bar charts using GraphPad Prism
(GraphPad Software, La Jolla, CA) and each bar represents the
mean ±standard error of the mean (SEM). For sow and litter data,
the sow or the litter represented the experimental unit. Statistical
signicance of reproductive performance (piglet mean BW at birth
and placental efciency) was determined by unpaired Student's t-
test using SPSS 20.0 (SPSS Inc., Chicago, USA) software. The IUGR
rate was analyzed using the Chi-square test. Data from 6 duplicate
placental samples were analyzed as a 2 2 factorial treatment
arrangement using the general linear model procedure of SAS (SAS
Inst. Inc., Cary, NC, USA) unless otherwise specied (also analyzed
using unpaired Student's t-test). The model utilized included the
main factors of piglet birth weight (factor 1 ¼IUGR), adenosine
supplementation (factor 2 ¼Ado) and their interaction
(IUGR Ado). Differences were considered signicant at P<0.05,
and a tendency was considered at 0.05 P<0.1.
3. Results
3.1. Characteristics of piglets
As shown in Fig. 1, the Ado group was higher than the Con group
for piglet mean birth weight (P<0.001) and placental efciency
(P<0.01) (Fig. 1A and B), but had a lower IUGR rate (P<0.01)
(Fig. 1C).
3.2. Placental vessel density
Fig. 2 shows the immunostaining results of placental vascular
density and VCAM1 expression in Normal and IUGR fetuses in the
Con and Ado groups. As shown in the gure, the placenta from
normal piglets had higher placental vascular density (P<0.01) and
VCAM1 expression (P<0.01) compared to the placenta from IUGR
piglets. Adenosine treatment also increased the placental vascular
density (P<0.01) and the expression level of VCAM1 (P<0.01).
Moreover, an interaction effect was observed between IUGR and
Ado in their effect on VCAM1 expression (P<0.01).
3.3. mRNA abundance of placental angiogenesis
The effects of adenosine and birth weight of newborn piglets
on placental angiogenesis were further explored by analyzing the
mRNA expression of angiogenesis-related genes. A total of 7
angiogenesis-related genes were evaluated by qRT-PCR (Fig. 3).
The IUGR placenta had a marked decrease in the mRNA
expression of VEGF-A (P<0.01) and TGF-1
b
(P<0.05). The
adenosine treatment had an up-regulated trend in the mRNA
expression of Ang (P¼0.06). Moreover, an interaction effect was
observed in VEGF-A and TGF-1
b
mRNA expression between IUGR
and Ado (P<0.05). Interestingly, in t-test analysis, the mRNA
levels of VEGF-A and Ang in the IUGR placenta were decreased
compared to the Normal placenta in the Con group (P<0.05),
and had a rescued trend in adenosine treatment (P¼0.07 and
P¼0.08). However, in normal placenta, there was no difference
in the mRNA levels of VEGF-A and Ang in adenosine treatment
(P>0.05).
3.4. Expression of adenosine receptors in placenta
Next, the expression level of adenosine receptors in the
placenta for IUGR and normal piglets were evaluated. As shown in
Fig. 4AeD, the IUGR factor had no signicant effect on mRNA
levels of placental adenosine receptors, but the ADORA2A
expression level was decreased in the IUGR placenta in immu-
nostaining analysis (P<0.01). In addition, the mRNA expression of
both ADORA2A (P<0.01) and ADORA2B (P<0.05) revealed an
increase with adenosine treatment, and similar results were also
found in immunostaining analysis in that the expression level of
ADORA2A was increased with adenosine treatment (P<0.01)
(Fig. 4E and F). The results also showed an interaction effect be-
tween IUGR and Ado in the relative uorescence density of
ADORA2A (P<0.01).
3.5. Protein levels of placental angiogenesis and adenosine
receptors
Fig. 5 displays the protein levels of angiogenesis-related markers
and adenosine receptors estimated by Western blotting. The results
showed that the expression of the angiogenesis-related signaling
pathway proteins p-Stat3 and p-Akt were decreased in the IUGR
placenta (P<0.05). Only ADORA2A had a lower protein level in the
IUGR placenta (P<0.05). Moreover, adenosine treatment notably
increased the protein expression levels of VCAM-1 (P<0.01), VEGF-
A(P<0.05) and Ang (P<0.01). Similar results were also observed
Fig. 1. Effects of maternal adenosine supplementation on the characteristics of piglets. (A) Piglet mean body weight (BW) at birth. (B) Placental efciency ¼piglet weight (g)/
placental weight (g). Data were analyzed by unpaired Student's t-test. (C) Intrauterine growth restriction (IUGR) rate was analyzed using the Chi-square test. The number of sows
was 44 in each group. All data are presented as mean ±SEM.
**
P<0.01,
***
P<0.001.
Z. Wu, J. Nie, D. Wu et al. Animal Nutrition 13 (2023) 282e288
284
in the protein expression of p-Stat3 and p-Akt (P<0.01). Adenosine
treatment also increased the protein expression of ADORA2A
(P<0.01) and ADORA3 (P<0.05). An interaction effect was
observed in p-Stat3 and p-Akt protein expression between IUGR
and Ado (P<0.01), as well as a trend in interaction effect on the
protein level of VCAM1 (P¼0.09) and ADORA2A (P¼0.06).
Fig. 3. Real-Time PCR mRNA expression analysis of angiogenesis-related factors in placenta. (A) VEGF -A, (B) EGF, (C) Ang, (D) HIF-1
a
, (E) bFGF, (F) TGF-1
b
, (G) PDGF-A.n¼6. Statistical
signicance was determined by 2 2 factorial treatment arrangement; factor 1 ¼IUGR; factor 2 ¼Ado; interaction between factor 1 and 2 ¼IUGR Ado. All data are presented as
mean ±SEM. The statistical signicance in (A) and (C) were also determined by unpaired Student's t-test.
*
P<0.05, IUGR þCon vs. Normal þCon. IUGR ¼intrauterine growth
restriction; Ado ¼adenosine group; VEGF-A ¼vascular endothelial growth factor A; Ang ¼angiogenin.
Fig. 2. Effects of maternal adenosine supplementation on the vascular density of placenta. (A, B) The H&E method was used to detect blood vessel density in the placenta, and the
black arrows point to the placental blood vessels (bar ¼250
m
m, n¼6). (C, D) VCAM1 immunouorescence staining in the placenta. (bar ¼50
m
m, n¼6). Statistical signicance was
determined by 2 2 factorial treatment arrangement, factor 1 ¼IUGR, factor 2 ¼Ado, interaction between factor 1 and 2 ¼IUGR Ado. All data are presented as mean ±SEM.
IUGR ¼intrauterine growth restriction; Ado ¼adenosine group; VCAM1 ¼vascular cell adhesion molecule-1.
Z. Wu, J. Nie, D. Wu et al. Animal Nutrition 13 (2023) 282e288
285
4. Discussion
Previous studies have widely reported that abnormal placental
angiogenesis is associated with IUGR occurrence (Hu et al., 2020;
Tan et al., 2022), suggesting that improving the placental angio-
genesis might alleviate adverse pregnancy outcomes (Huang et al.,
2021a,2021b). Despite previous reports about the potential of
adenosine in promoting angiogenesis, the role of adenosine in
placental angiogenesis remains unclear. Pigs, as animals commonly
used in biomedical research on human pregnancy, have been
favored due to the physiological similarities they have to humans
(Bazer et al., 2012;Cai et al., 2018). In this study, we investigated
whether maternal adenosine supplementation during pregnancy
could improve pregnancy outcomes by detecting changes in
placental angiogenesis. Our results demonstrated that adenosine
supplementation could signicantly increase the mean birth
weight and placental efciency in piglets, and the Ado group was
shown to have a signicantly lower IUGR rate than the Con group
(6.84% vs 12.47%), suggesting the great potential of adenosine
supplementation to ameliorate pregnancy outcomes in sows.
The placenta plays an important role in fetal growth (Reynolds
et al., 2006;Zhao et al., 2020), and adequate placental angiogen-
esis is essential for successful pregnancy and optimal growth of the
fetus (Gualdoni et al., 2021). Thus, to further explore the different
effects of adenosine on Normal and IUGR fetuses, the placentae
from IUGR and normal-weight (Normal) fetuses were separately
collected as 2 groups for further analysis. The results showed that
the IUGR placenta had signicantly poorer angiogenesis, and
adenosine treatment could signicantly promote angiogenesis in
the placenta (especially in the IUGR placenta), as well as restore the
low expression of VEGF-A and Ang in the IUGR placenta. Notably,
there was an interaction effect between IUGR and Ado in the pro-
angiogenesis effect of adenosine, and adenosine had no signi-
cant effect on the mRNA expressions of angiogenesis-related genes
in the Normal placenta, suggesting that the benecial effects of
adenosine treatment on IUGR occurrence may be attributed to the
presence of poor angiogenesis in the IUGR placenta. These results
were consistent with several previous studies reporting that (1)
IUGR piglets had lower vessel density in the placenta compared to
normal piglets, coupled with lower CD31 and VEGF-A level
(Campos et al., 2012;Hu et al., 2020;Wang et al., 2017); (2) there
was a close relationship between adenosine and embryonic
development (Rivkees and Wendler, 2017); (3) adenosine signaling
can be activated to exert biological effects, including but not limited
to angiogenesis, by up-regulating the expression of angiogenesis
factors such as VEGF, TGF-1
b
and Ang (Bahreyni et al., 2018;Gorain
et al., 2019;Zhang et al., 2019).
Differential binding to adenosine receptors may be critical for
adenosine activity and its biological effects (Salsoso et al., 2017). In
this study, the mRNA level of 4 adenosine receptors in the placenta
was further evaluated. Interestingly, only the expression of
ADORA2A showed a signicant increase under adenosine treat-
ment both in the Normal and IUGR placenta. Although the mRNA
level of ADORA2B trended toward a similar expression with
ADORA2A, the changes in ADORA2B (up-regulated only 20% after
adenosine treatment) were much less than ADORA2A (up-regulated
nearly 50% after adenosine treatment). Further, immunostaining
analysis also showed that the expression of ADORA2A was simul-
taneously affected by IUGR and Ado, as well as their interaction
effects. These results seemed to imply that adenosine was more
Fig. 4. The expression of adenosine receptors in the placenta. (AeD) Real-Time PCR mRNA expression analysis of the adenosine receptors in the placenta (n¼6). (EeF) ADORA2A
immunouorescence staining in the placenta (bar ¼50
m
m, n¼6). Statistical signicance was determined by 2 2 factorial treatment arrangement; factor 1 ¼IUGR; factor
2¼Ado; interaction between factor 1 and 2 ¼IUGR Ado. All data are presented as mean ±SEM. IUGR ¼intrauterine growth restriction; Ado ¼adenosine group.
Z. Wu, J. Nie, D. Wu et al. Animal Nutrition 13 (2023) 282e288
286
likely to increase ADORA2A level to promote angiogenesis in the
IUGR placenta. The promoting effect of ADORA2A on angiogenesis
has been demonstrated in previous studies (Acurio et al., 2017;Liu
et al., 2017). Collectively, adenosine supplementation can up-
regulate ADORA2A level and improve angiogenesis in the IUGR
placenta.
Furthermore, the protein expression of angiogenesis-related
markers and adenosine receptors, as well as the possible underly-
ing mechanisms were explored. Only ADORA2A was found to have
the same expression trend as its mRNA expression (which
ADORA2B did not have), which further suggested the important
role ADORA2A plays in placental angiogenesis promoted by
adenosine. Similar results were also observed in angiogenesis-
related protein expression. Interestingly, the angiogenesis-related
signaling pathway Stat3 and Akt showed a similar expression
trend with angiogenesis markers. Previous studies also reported
that Stat3 is an important regulator in angiogenesis (Pereira et al.,
2015), and our previous study also demonstrated the ability of
Stat3 in improving placental angiogenesis (Hu et al., 2021;Huang
et al., 2021a). As the downstream signaling target of adenosine,
Akt also plays an important role in angiogenesis as previously re-
ported (Azambuja et al., 2019;Liu et al., 2017).
Fig. 5. Western blot protein expression analysis of angiogenesis-related factors (B, VCAM1; C, p-Stat3; D, p-Akt; E, VEGF-A; J, Ang) and adenosine receptors (F, ADORA3; G,
ADORA2B; H, ADORA2A; I, ADORA1) in the placenta. n¼6. Statistical signicance was determined by 2 2 factorial treatment arrangement; factor 1 ¼IUGR; factor 2 ¼Ado;
interaction between factor 1 and 2 ¼IUGR Ado. All data are presented as mean ±SEM. IUGR ¼intrauterine growth restriction; Ado ¼adenosine group.
Z. Wu, J. Nie, D. Wu et al. Animal Nutrition 13 (2023) 282e288
287
5. Conclusions
Impaired angiogenesis in the placenta during pregnancy was
shown to be associated with the occurrence of IUGR piglets, while
maternal adenosine supply of 1 g/kg during the gestation of sows
could promote angiogenesis in placentae (especially in IUGR
placentae), nally increase the piglet birth weight and reduce the
IUGR rate. The underlying mechanism for the positive effects of
adenosine might be linked to the activation of ADORA2A and Stat3/
Akt signaling.
Author contributions
Chengquan Tan: Conceptualization, Methodology, Writing -
Review &Editing, Project administration. Hefeng Luo: Methodol-
ogy, Investigation, Writing - Original Draft. Zifang Wu: Investiga-
tion, Data Curation, Writing - Original Draft. Jiawei Nie:
Investigation, Data Curation. Deyuan Wu: Investigation. Shuangbo
Huang: Investigation. Jianzhao Chen: Investigation. Huangjin
Liang: Resources. Xiangyu Hao: Resources. Li Feng: Resources.
Declaration of competing interest
We declare that we have no nancial and personal relationships
with other people or organizations that can inappropriately inu-
ence our work, and there is no professional or other personal in-
terest of any nature or kind in any product, service and/or company
that could be construed as inuencing the content of this paper.
Acknowledgements
The present work was jointly supported by the National Key
R&D Program of China (2021YFD1300401) and Natural Science
Foundation of Guangdong Province (2021A1515012116).
Appendix supplementary data
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.aninu.2023.02.003.
References
Acurio J, Herlitz K, Troncoso F, Aguayo C, Bertoglia P, Escudero C. Adenosine a2a
receptor regulates expression of vascular endothelial growth factor in feto-
placental endothelium from normal and late-onset pre-eclamptic pregnan-
cies. Purinergic Signal 2017;13:51e60.
Aditya I, Tat V, Sawana A, Mohamed A, Tuffner R, Mondal T. Use of Doppler
velocimetry in diagnosis and prognosis of intrauterine growth restriction
(iugr): a review. J Neonatal Perinat Med 2016;9:117e26.
Antonioli L, Fornai M, Pellegrini C, D'antongiovanni V, Turiello R, Morello S,
Hasko G, Blandizzi C. Adenosine signaling in the tumor microenvironment. Adv
Exp Med Biol 2021;1270:145e67.
Azambuja JH, Gelsleichter NE, Beckenkamp LR, Iser IC, Fernandes MC, Figueiro F,
Battastini AMO, Scholl JN, De Oliveira FH, Spanevello RM, Sevigny J, Wink MR,
Stefani MA, Teixeira HF, Braganhol E. Cd73 downregulation decreases in vitro
and in vivo glioblastoma growth. Mol Neurobiol 2019;56:3260e79.
Bahreyni A, Khazaei M, Rajabian M, Ryzhikov M, Avan A, Hassanian SM. Therapeutic
potency of pharmacological adenosine receptor agonist/antagonist in angio-
genesis, current status and perspectives. J Pharm Pharmacol 2018;70:191e6.
Bazer FW, Song G, Kim J, Dunlap KA, Sattereld MC, Johnson GA, Burghardt RC,
Wu G. Uterine biology in pigs and sheep. J Anim Sci Biotechnol 2012;3:23.
Cai S, Zhu J, Zeng X, Ye Q, Ye C, Mao X, Zhang S, Qiao S, Zeng X. Maternal n-car-
bamylglutamate supply during early pregnancy enhanced pregnancy outcomes
in sows through modulations of targeted genes and metabolism pathways.
J Agric Food Chem 2018;66:5845e52.
Campos PH, Silva BA, Donzele JL, Oliveira RF, Knol EF. Effects of sow nutrition during
gestation on within-litterbir thweight variation: a review. Animal 2012;6:797e806.
Escudero C, Bertoglia P, Hernadez M, Celis C, Gonzalez M, Aguayo C, Acurio J.
Impaired a2a adenosine receptor/nitric oxide/vegf signaling pathway in fetal
endothelium during late- and early-onset preeclampsia. Purinergic Signal
2013;9:215e26.
Fernandez P, Jara C, Aguilera V, Caviedes L, Diaz F, Radojkovic C, Veas C, Lamperti L,
Escudero C, Aguayo C. Adenosine a(2)a and a(3) receptors are involved in the
human endothelial progenitor cells migration. J Cardiovasc Pharmacol 2012;59:
397e404.
Freking BA, Lents CA, Vallet JL. Selection for uterine capacity improves lifetime
productivity of sows. Anim Reprod Sci 2016;167:16e21.
Gorain B, Choudhury H, Yee GS, Bhattamisra SK. Adenosine receptors as novel
targets for the treatment of various cancers. Curr Pharmaceut Des 2019;25:
2828e41.
Gualdoni GS, Jacobo PV, Barril C, Ventureira MR, Cebral E. Early abnormal placen-
tation and evidence of vascular endothelial growth factor system dysregulation
at the feto-maternal interface after periconceptional alcohol consumption.
Front Physiol 2021;12:815760.
Hu C, Wu Z, Huang Z, Hao X, Wang S, Deng J, Yin Y, Tan C. Nox2 impairs vegf-a-
induced angiogenesis in placenta via mitochondrial ros-stat3 pathway. Redox
Biol 2021;45:102051.
Hu C, Yang Y, Deng M, Yang L, Shu G, Jiang Q, Zhang S, Li X, Yin Y, Tan C, Wu G.
Placentae for low birth weight piglets are vulnerable to oxidative stress,
mitochondrial dysfunction, and impaired angiogenesis. Oxid Med Cell Longev
2020;2020:8715412.
Huang S, Wu Z, Huang Z, Hao X, Zhang L, Hu C, Wei J, Deng J, Tan C. Maternal supply
of cysteamine alleviates oxidative stress and enhances angiogenesis in porcine
placenta. J Anim Sci Biotechnol 2021a;12:91.
Huang Z, Huang S, Song T, Yin Y, Tan C. Placental angiogenesis in mammals: a re-
view of the regulatory effects of signaling pathways and functional nutrients.
Adv Nutr 2021b;12:2415e34.
Liu Z, Yan S, Wang J, Xu Y, Wang Y, Zhang S, Xu X, Yang Q, Zeng X, Zhou Y, Gu X,
Lu S, Fu Z, Fulton DJ, Weintraub NL, Caldwell RB, Zhang W, Wu C, Liu XL,
Chen JF, Ahmad A, Kaddour-Djebbar I, Al-Shabrawey M, Li Q, Jiang X, Sun Y,
Sodhi A, Smith L, Hong M, Huo Y. Endothelial adenosine a2a receptor-mediated
glycolysis is essential for pathological retinal angiogenesis. Nat Commun
2017;8:584.
NRC. Nutrient requirements of swine. 11th revised edn. Washington, DC: National
Academy Press; 2012.
Oksbjerg N, Nissen PM, Therkildsen M, Moller HS, Larsen LB, Andersen M, Young JF.
Meat science and muscle biology symposium: in utero nutrition related to fetal
development, postnatal performance, and meat quality of pork. J Anim Sci
2013;91:1443e53.
Pereira RD, De Long NE, Wang RC, Yazdi FT, Holloway AC, Raha S. Angiogenesis in
the placenta: the role of reactive oxygen species signaling. BioMed Res Int
2015;2015:814543.
Reynolds LP, Caton JS, Redmer DA, Grazul-Bilska AT, Vonnahme KA, Borowicz PP,
Luther JS, Wallace JM, Wu G, Spencer TE. Evidence for altered placental blood
ow and vascularity in compromised pregnancies. J Physiol 2006;572:51e8.
Rivkees SA, Wendler CC. Long-term consequences of disrupting adenosine signaling
during embryonic development. Mol Aspect Med 2017;55:110e7.
Salsoso R, Farias M, Gutierrez J, Pardo F, Chiarello DI, Toledo F, Leiva A, Mate A,
Vazquez CM, Sobrevia L. Adenosine and preeclampsia. Mol Aspect Med
2017;55:126e39.
Sun C, Groom KM, Oyston C, Chamley LW, Clark AR, James JL. The placenta in fetal
growth restriction: what is going wrong? Placenta 2020;96:10e8.
Tan C, Huang Z, Xiong W, Ye H, Deng J, Yin Y. A review of the amino acid metabolism
in placental function response to fetal loss and low birth weight in pigs. J Anim
Sci Biotechnol 2022;13:28.
Troncoso F, Herlitz K, Acurio J, Aguayo C, Guevara K, Castro FO, Godoy AS, San
Martin S, Escudero C. Advantages in wound healing process in female mice
require upregulation a2a-mediated angiogenesis under the stimulation of
17beta-estradiol. Int J Mol Sci 2020;21.
Valls MD, Soldado M, Arasa J, Perez-Aso M, Williams AJ, Cronstein BN, Noguera MA,
Terencio MC, Montesinos MC. Annexin a2-mediated plasminogen activation in
endothelial cells contributes to the proangiogenic effect of adenosine a2a re-
ceptors. Front Pharmacol 2021;12:654104.
Wang J, Feng C, Liu T, Shi M, Wu G, Bazer FW. Physiological alterations associated
with intrauterine growth restriction in fetal pigs: causes and insights for
nutritional optimization. Mol Reprod Dev 2017;84:897e904.
Wilson ME, Biensen NJ, Ford SP. Novel insight into the control of litter size in pigs,
using placental efciency as a selection tool. J Anim Sci 1999;77:1654e8.
Wu G, Bazer FW, Wallace JM, Spencer TE. Board-invited review: intrauterine growth
retardation: implications for the animal sciences. J Anim Sci 2006;84:2316e37.
Zhang HX, Yuan J, Li YF, Li RS. Thalidomide decreases high glucose-induced
extracellular matrix protein synthesis in mesangial cells via the ampk
pathway. Exp Ther Med 2019;17:927e34.
Zhang L, Tan C, Xin Z, Huang S, Ma J, Zhang M, Shu G, Luo H, Deng B, Jiang Q, Deng J.
Uplc-orbitrap-ms/ms combined with biochemical analysis to determine the
growth and development of mothers and fetuses in different gestation periods
on Tibetan sow model. Front Nutr 2022;9.
Zhao S, Zhong S, Wang F, Wang H, Xu D, Li G. Microcystin-lr exposure decreased
the fetal weight of mice by disturbance of placental development and ros-
mediated endoplasmic reticulum stress in the placenta. Environ Pollut
2020;256:113362.
Z. Wu, J. Nie, D. Wu et al. Animal Nutrition 13 (2023) 282e288
288
... Recent studies have shown that nutritional interventions in sows can effectively reduce the incidence of IUGR. For instance, Pieszka et al. (7) showed the effectiveness of supplementing sow diets with pancreatic-like enzymes, while Wu et al. (8) found that supplementation with adenosine was also effective in reducing the occurrence of IUGR. However, current IUGR research primarily emphasizes direct maternal effects on the fetus and the characterization of the IUGR placenta. ...
... Our Findings indicating impaired placental nutrient transport as a contributing factor to IUGR, COS supplementation during late gestation effectively ameliorated decreased nutrient transport function following placental injury. Previous studies have emphasized the importance of adequate vascularization within the placenta for normal fetal development (24), however, IUGR placentas exhibited significantly poorer vascular development compared to normal placentas (8). In this study, it was found that impaired vascular growth in sow placenta appeared to be another factor contributing to the emergence of IUGR. ...
Article
Full-text available
Maternal dietary supplementation with chitosan oligosaccharide (COS) has been considered as a potential intervention to mitigate the occurrence of intrauterine growth restriction (IUGR) and improve postnatal growth. The present study investigated the effect of COS as a dietary supplement for sows during late gestation and lactation on their productivity, placental function, and the intestinal health of IUGR piglets. From day (d) 85 of late gestation to d 21 of lactation, 30 sows were randomly divided into either a control group (basal diet) or a COS group (basal diet + 100 mg kg⁻¹ COS). At d 21 of lactation, eight normal and eight IUGR littermates from eight litters belong to control sows, as well as eight IUGR littermates from COS sows, were selected for further analysis. The results showed a significant reduction in the number of stillbirths and mummies in COS groups (p < 0.05). Maternal dietary supplementation with COS also significantly up-regulated the expression levels of GLUT1, GLUT3, and VEGFA mRNA in the placenta of IUGR piglets compared to those in control group (p < 0.05). Furthermore, there was a significant decrease in MDA content and a significant increase in GSH content in the placenta of IUGR piglets from COS sows compared to those from control group (p < 0.05). Additionally, the expression levels of MUC2 and occludin mRNA as well as claudin1 protein significantly up-regulated in the jejunum of 21-day-old IUGR piglets from COS sows group compared to those from control group (p < 0.05). Moreover, IL-10 mRNA expression level was significantly increased while MDA content was significantly reduced in the jejunum of 21-day-old IUGR piglets from COS sows group compared to those from control group (p < 0.05). The results indicated that maternal dietary COS supplementation during late gestation effectively reduced the incidence of stillbirths and mummies, potentially linked to enhanced placental function, reduced oxidative stress, and improved immune status. Furthermore, maternal dietary COS supplementation exhibited positive impact on intestinal digestive and absorptive function, intestinal barrier integrity, intestinal antioxidant capacity and immune status in 21-day-old suckling IUGR piglets.
... The number and the birth weights of newborn piglets were documented. To reduce the Animals 2024, 14, 689 3 of 17 differences between placental samples, the placenta located at 3 to 4 cm from the cord insertion point was immediately collected based on previous study [18]. The samples were immediately snap-frozen in liquid nitrogen, or fixed in 4% paraformaldehyde as described previously [19]. ...
Article
Full-text available
The blood vessels of the placenta are crucial for fetal growth. Here, lower vessel density and ornithine (Orn) content were observed in placentae for low-birth-weight fetuses versus normal-birth-weight fetuses at day 75 of gestation. Furthermore, the Orn content in placentae decreased from day 75 to 110 of gestation. To investigate the role of Orn in placental angiogenesis, 48 gilts (Bama pig) were allocated into four groups. The gilts in the control group were fed a basal diet (CON group), while those in the experimental groups were fed a basal diet supplemented with 0.05% Orn (0.05% Orn group), 0.10% Orn (0.10% Orn group), and 0.15% Orn (0.15% Orn group), respectively. The results showed that 0.15% Orn and 0.10% Orn groups exhibited increased birth weight of piglets compared with the CON group. Moreover, the 0.15% Orn group was higher than the CON group in the blood vessel densities of placenta. Mechanistically, Orn facilitated placental angiogenesis by regulating vascular endothelial growth factor-A (VEGF-A). Furthermore, maternal supplementation with 0.15% Orn during gestation increased the jejunal and ileal villi height and the concentrations of colonic propionate and butyrate in suckling piglets. Collectively, these results showed that maternal supplementation with Orn promotes placental angiogenesis and improves intestinal development of suckling piglets.
... In general, it is acknowledged that the placenta, and more particularly, the trophoblasts, play a significant role in the formation of PE because multinucleated trophoblasts, which are a hallmark of embryonic implantation, penetrate the uterine epithelium [8]. Thus, the disorder in trophoblast activities, especially defects in the invasion into the uterus will cause the failure in the maternal spiral arteries remodeling and now is conceived as the central mechanism underlying the initiation of PE [9,10]. Given the key role of trophoblasts in the progression of PE, elucidating the detail mechanism mediating trophoblast cell differentiation, especially differentiation toward the invasive pathway, will provide valuable information for explanation of the pathogenesis of PE and identify novel diagnostic Vol. ...
Article
The development of preeclampsia (PE) is associated with the impaired trophoblast motility. MicroRNAs (miRs) contribute to the modulation of trophoblast invasion. In the current study, the role of miR-206/AGTR1 in the TNF-α-induced invasion defect of trophoblasts was explored. The levels of miR-206 and ATGR1 in clinical placenta tissues were investigated. Trophoblasts were treated with TNF-α, and the levels of miR-206 and ATGR1 were modulated. Changes in cell viability, invasion, and inflammation in trophoblasts were detected. The level of miR-206 was induced, while the level of AGTR1 was suppressed in placenta tissues. In in vitro assays, TNF-α suppressed viability, induced inflammatory response, inhibited invasion, upregulated miR-206, and down-regulated AGTR1. The inhibited expression of miR-206 or the overexpression of AGTR1 counteracted the effects of TNF-α, indicating the key role of the miR-206/AGTR1 in progression of PE. Collectively, miR-206 suppressed viability, induced inflammatory response, and decreased invasion of trophoblasts by inhibiting AGTR1.
... IUGR is typically characterized by lower growth rates and organ development than normal for gestational age, with higher postnatal morbidity and mortality [50] and a greater risk of metabolic, reproductive, immune, and respiratory abnormalities [9,10]. The incidence of IUGR in pigs is 15-25%, causing serious losses to livestock production [51]. The pig is also a model animal for human development and disease research with a high degree of homology with humans. ...
Article
Full-text available
microRNAs are a class of small RNAs that have been extensively studied, which are involved in many biological processes and disease occurrence. The incidence of intrauterine growth restriction is higher in mammals, especially multiparous mammals. In this study, we found that the weight of the longissimus dorsi of intrauterine growth-restricted pigs was significantly lower than that of normal pigs. Then, intrauterine growth-restricted pig longissimus dorsi were used to characterize miRNA expression profiles by RNA sequencing. A total of 333 miRNAs were identified, of which 26 were differentially expressed. Functional enrichment analysis showed that these differentially expressed miRNAs regulate the expression of their target genes (such as PIK3R1, CCND2, AKT3, and MAP3K7), and these target genes play an important role in the proliferation and differentiation of skeletal muscle through signaling pathways such as the PI3K-Akt, MAPK, and FoxO signaling pathways. Furthermore, miRNA-451 was significantly upregulated in IUGR pig skeletal muscle. Overexpression of miR-451 in C2C12 cells significantly promoted the expression of Mb, Myod, Myog, Myh1, and Myh7, suggesting that miR-451 may be involved in the regulation of the myoblastic differentiation of C2C12 cells. Our results reveal the role of miRNA-451 in regulating myogenic differentiation of skeletal muscle in pigs with intrauterine growth restriction.
Article
Full-text available
Adenosine receptors (ARs) are widely acknowledged pharmacological targets yet are still underutilized in clinical practice. Their ubiquitous distribution in almost all cells and tissues of the body makes them, on the one hand, excellent candidates for numerous diseases, and on the other hand, intrinsically challenging to exploit selectively and in a site-specific manner. This review endeavors to comprehensively depict the substantial advancements witnessed in recent years concerning the development of drugs that modulate ARs. Through preclinical and clinical research, it has become evident that the modulation of ARs holds promise for the treatment of numerous diseases, including central nervous system disorders, cardiovascular and metabolic conditions, inflammatory and autoimmune diseases, and cancer. The latest studies discussed herein shed light on novel mechanisms through which ARs exert control over pathophysiological states. They also introduce new ligands and innovative strategies for receptor activation, presenting compelling evidence of efficacy along with the implicated signaling pathways. Collectively, these emerging insights underscore a promising trajectory toward harnessing the therapeutic potential of these multifaceted targets.
Article
Full-text available
Pregnancy is a complex and dynamic process, the physiological and metabolite changes of the mother are affected by different pregnancy stages, but little information is available about their changes and potential mechanisms during pregnancy, especially in blood and amniotic fluid. Here, the maternal metabolism rules at different pregnancy stages were investigated by using a Tibetan sow model to analyze the physiological hormones and nutrient metabolism characteristics of maternal serum and amniotic fluid as well as their correlations with each other. Our results showed that amniotic fluid had a decrease (P < 0.05) in the concentrations of glucose, insulin and hepatocyte growth factor as pregnancy progressed, while maternal serum exhibited the highest concentrations of glucose and insulin at 75 days of gestation (P < 0.05), and a significant positive correlation (P < 0.05) between insulin and citric acid. Additionally, T4 and cortisol had the highest levels during late gestation (P < 0.05). Furthermore, metabolomics analysis revealed significant enrichment in the citrate cycle pathway and the phenylalanine/tyrosine/tryptophan biosynthesis pathway (P < 0.05) with the progress of gestation. This study clarified the adaptive changes of glucose, insulin and citric acid in Tibetan sows during pregnancy as well as the influence of aromatic amino acids, hepatocyte growth factor, cortisol and other physiological indicators on fetal growth and development, providing new clues for the normal development of the mother and the fetus, which may become a promising target for improving the well-being of pregnancy.
Article
Full-text available
The fertility of sows mainly depends on the embryo losses during gestation and the survival rate of the post-farrowing piglets. The selection of highly-prolific sows has been mainly focused on the selection of genotypes with high ovulatory quota. However, in the early- and post-implantation stages, the rate of embryo losses was increased with the increase of zygotes. Among the various factors, placental growth and development is the vital determinant for fetal survival, growth, and development. Despite the potential survival of fetuses with deficient placental development, their life-conditions and growth can be damaged by a process termed intrauterine growth retardation (IUGR). The newborn piglets affected by IUGR are prone to increased morbidity and mortality rates; meanwhile, the growth, health and welfare of the surviving piglets will remain hampered by these conditions, with a tendency to exacerbate with age. Functional amino acids such as glycine, proline, and arginine continue to increase with the development of placenta, which are not only essential to placental growth (including vascular growth) and development, but can also be used as substrates for the production of glutathione, polyamines and nitric oxide to benefit placental function in many ways. However, the exact regulation mechanism of these amino acids in placental function has not yet been clarified. In this review, we provide evidence from literature and our own work for the role and mechanism of dietary functional amino acids during pregnancy in regulating the placental functional response to fetal loss and birth weight of piglets. This review will provide novel insights into the response of nutritionally nonessential amino acids (glycine and proline) to placental development as well as feasible strategies to enhance the fertility of sows.
Article
Full-text available
Adequate placentation, placental tissue remodeling and vascularization is essential for the success of gestation and optimal fetal growth. Recently, it was suggested that abnormal placenta induced by maternal alcohol consumption may participate in fetal growth restriction and relevant clinical manifestations of the Fetal Alcohol Spectrum Disorders (FASD). Particularly, periconceptional alcohol consumption up to early gestation can alter placentation and angiogenesis that persists in pregnancy beyond the exposure period. Experimental evidence suggests that abnormal placenta following maternal alcohol intake is associated with insufficient vascularization and defective trophoblast development, growth and function in early gestation. Accumulated data indicate that impaired vascular endothelial growth factor (VEGF) system, including their downstream effectors, the nitric oxide (NO) and metalloproteinases (MMPs), is a pivotal spatio-temporal altered mechanism underlying the early placental vascular alterations induced by maternal alcohol consumption. In this review we propose that the periconceptional alcohol intake up to early organogenesis (first trimester) alters the VEGF-NO-MMPs system in trophoblastic-decidual tissues, generating imbalances in the trophoblastic proliferation/apoptosis, insufficient trophoblastic development, differentiation and migration, deficient labyrinthine vascularization, and uncompleted remodelation and transformation of decidual spiral arterioles. Consequently, abnormal placenta with insufficiency blood perfusion, vasoconstriction and reduced labyrinthine blood exchange can be generated. Herein, we review emerging knowledge of abnormal placenta linked to pregnancy complications and FASD produced by gestational alcohol ingestion and provide evidence of the early abnormal placental angiogenesis-vascularization and growth associated to decidual-trophoblastic dysregulation of VEGF system after periconceptional alcohol consumption up to mid-gestation, in a mouse model.
Article
Full-text available
Background Oxidative stress in placenta is associated with the occurrence of adverse pregnancy outcomes in sow, but there are few satisfactory treatment strategies for these conditions. This study investigated the potential of cysteamine (CS) as an antioxidant protectant for regulating the reproductive performance, redox status, and placental angiogenesis of sows. Methods The placental oxidative stress status and vascular density of piglets with different birth weights: < 1.0 kg (low birth weight, LBW) and 1.4–1.6 kg (normal birth weight, NBW) were evaluated, followed by allotting 84 sows to four treatments ( n = 21) and feeding them with a basal diet supplemented with 0, 100, 300, or 500 mg/kg of CS from d 85 of gestation to d 21 of lactation, respectively. Placenta, serum, and colostrum samples of sows or piglets were collected, and the characteristics of sows and piglets were recorded. Furthermore, the in vivo results were validated using porcine vascular endothelial cells (PVECs). Results Compared with the NBW placentae, the LBW placentae showed increased oxidative damage and were vulnerable to angiogenesis impairment. Particularly, H 2 O 2 -induced oxidative stress prompted intracellular reactive oxygen species generation and inhibited the tube formation and migration of PVECs as well as the expression of vascular endothelial growth factor-A (VEGF-A) in vitro . However, dietary CS supplementation can alleviate oxidative stress and improve the reproductive performance of sows. Specifically, compared with the control group, dietary 100 mg/kg CS could (1) decrease the stillbirth and invalid rates, and increase both the piglet birth weight in the low yield sows and the placental efficiency; (2) increase glutathione and reduce malondialdehyde in both the serum and the colostrum of sows; (3) increase the levels of total antioxidant capacity and glutathione in LBW placentae; (4) increase the vascular density, the mRNA level of VEGF-A , and the immune-staining intensity of platelet endothelial cell adhesion molecule-1 in the LBW placentae. Furthermore, the in vitro experiment indicated that CS pre-treatment could significantly reverse the NADPH oxidase 2-ROS-mediated inactivation of signal transducer and activator of transcription-3 (Stat3) signaling pathway induced by H 2 O 2 inhibition of the proliferation, tube formation, and migration of PVECs. Meanwhile, inhibition of Stat3 significantly decreased the cell viability, tube formation and the VEGF-A protein level in CS pretreated with H 2 O 2 -cultured PVECs. Conclusions The results indicated that oxidative stress and impaired angiogenesis might contribute to the occurrence of LBW piglets during pregnancy, but CS supplementation at 100 mg/kg during late gestation and lactation of sows could alleviate oxidative stress and enhance angiogenesis in placenta, thereby increasing birth weight in low yield sows and reducing stillbirth rate. The in vitro data showed that the underlying mechanism for the positive effects of CS might be related to the activation of Stat3 in PVECs.
Article
Full-text available
Normal placental development and proper angiogenesis are essential for fetal growth during pregnancy. Angiogenesis involves the regulatory action of many angiogenic factors and a series of signal transduction processes inside and outside the cell. The obstruction of placental angiogenesis causes fetal growth restriction and serious pregnancy complications, even leading to fetal loss and pregnancy cessation. In this review, the effects of placental angiogenesis on fetal development are described, and several signaling pathways related to placental angiogenesis and their key regulatory mediators are summarized. These factors, which include vascular endothelial growth factor (VEGF)-VEGF receptor, delta-like ligand 4 (DLL-4)-Notch, Wnt, and Hedgehog, may affect the placental angiogenesis process. Moreover, the degree of vascularization depends on cell proliferation, migration, and differentiation, which is affected by the synthesis and secretion of metabolites or intermediates and mutual coordination or inhibition in these pathways. Furthermore, we discuss recent advances regarding the role of functional nutrients (including amino acids and fatty acids) in regulating placental angiogenesis. Understanding the specific mechanism of placental angiogenesis and its influence on fetal development may facilitate the establishment of new therapeutic strategies for the treatment of preterm birth, pre-eclampsia, or intrauterine growth restriction, and provide a theoretical basis for formulating nutritional regulation strategies during pregnancy.
Article
Full-text available
Aberrant placental angiogenesis is associated with fetal intrauterine growth restriction (IUGR), but the mechanism underlying abnormal placental angiogenesis remains largely unknown. Here, lower vessel density and higher expression of NADPH oxidases 2 (Nox2) were observed in the placentae for low birth weight (LBW) fetuses versus normal birth weight (NBW) fetuses, with a negative correlation between Nox2 and placental vessel density. Moreover, it was revealed for the first time that Nox2 deficiency facilitates angiogenesis in vitro and in vivo, and vascular endothelial growth factor-A (VEGF-A) has an essential role in Nox2-controlled inhibition of angiogenesis in porcine vascular endothelial cells (PVECs). Mechanistically, Nox2 inhibited phospho-signal transducer and activator of transcription 3 (p-STAT3) in the nucleus by inducing the production of mitochondrial reactive oxygen species (ROS). Dual-luciferase assay confirmed that knockdown of Nox2 reduces the expression of VEGF-A in an STAT3 dependent manner. Our results indicate that Nox2 is a potential target for therapy by increasing VEGF-A expression to promote angiogenesis and serves as a prognostic indicator for fetus with IUGR.
Article
Full-text available
Adenosine A2A receptor mediates the promotion of wound healing and revascularization of injured tissue, in healthy and animals with impaired wound healing, through a mechanism depending upon tissue plasminogen activator (tPA), a component of the fibrinolytic system. In order to evaluate the contribution of plasmin generation in the proangiogenic effect of adenosine A2A receptor activation, we determined the expression and secretion of t-PA, urokinase plasminogen activator (uPA), plasminogen activator inhibitor-1 (PAI-1) and annexin A2 by human dermal microvascular endothelial cells stimulated by the selective agonist CGS-21680. The plasmin generation was assayed through an enzymatic assay and the proangiogenic effect was studied using an endothelial tube formation assay in Matrigel. Adenosine A2A receptor activation in endothelial cells diminished the release of PAI-1 and promoted the production of annexin A2, which acts as a cell membrane co-receptor for plasminogen and its activator tPA. Annexin A2 mediated the increased cell membrane-associated plasmin generation in adenosine A2A receptor agonist treated human dermal microvascular endothelial cells and is required for tube formation in an in vitro model of angiogenesis. These results suggest a novel mechanism by which adenosine A2A receptor activation promotes angiogenesis: increased endothelial expression of annexin A2, which, in turn, promotes fibrinolysis by binding tPA and plasminogen to the cell surface.
Chapter
Full-text available
Adenosine, deriving from ATP released by dying cancer cells and then degradated in the tumor environment by CD39/CD73 enzyme axis, is linked to the generation of an immunosuppressed niche favoring the onset of neoplasia. Signals delivered by extracellular adenosine are detected and transduced by G-protein-coupled cell surface receptors, classified into four subtypes: A1, A2A, A2B, and A3. A critical role of this nucleoside is emerging in the modulation of several immune and nonimmune cells defining the tumor microenvironment, providing novel insights about the development of novel therapeutic strategies aimed at undermining the immune-privileged sites where cancer cells grow and proliferate.
Article
Full-text available
Estrogenic steroids and adenosine A 2A receptors promote the wound healing and angiogenesis processes. However, so far, it is unclear whether estrogen may regulate the expression and pro-angiogenic activity of A 2A receptors. Using in vivo analyses, we showed that female wild type (WT) mice have a more rapid wound healing process than female or male A 2A-deficient mice (A 2A KO) mice. We also found that pulmonary endothelial cells (mPEC) isolated from female WT mice showed higher expression of A 2A receptor than mPEC from male WT mice. mPEC from female WT mice were more sensitive to A 2A-mediated pro-angiogenic response, suggesting an ER and A 2A crosstalk, which was confirmed using cells isolated from A 2A KO. In those female cells, 17β-estradiol potentiated A 2A-mediated cell proliferation, an effect that was inhibited by selective antagonists of estrogen receptors (ER), ERα, and ERβ. Therefore, estrogen regulates the expression and/or pro-angiogenic activity of A 2A adenosine receptors, likely involving activation of ERα and ERβ receptors. Sexual dimorphism in wound healing observed in the A 2A KO mice process reinforces the functional crosstalk between ER and A 2A receptors.
Article
Full-text available
Intrauterine growth restriction (IUGR) is associated with fetal mortality and morbidity. One of the most common causes of IUGR is placental insufficiency, including placental vascular defects, and mitochondrial dysfunction. In addition, a high level of oxidative stress induces placental vascular lesions. Here, we evaluated the oxidative stress status, mitochondrial function, angiogenesis, and nutrient transporters in placentae of piglets with different birth weights: 700 g (H). Results showed that placentae from the L group had higher oxidative damage, lower adenosine triphosphate and citrate synthase levels, and lower vascular density, compared to those from the other groups. Protein expression of angiogenic markers, including vascular endothelial cadherin, vascular endothelial growth factor A, and platelet endothelial cell adhesion molecule-1, was the lowest in the L group placentae compared to the other groups. In addition, the protein levels of glucose transporters GLUT1 and GLUT3 were downregulated in the L group, compared to the other groups. Furthermore, oxidative stress induced by H2O2 inhibited tube formation and migration in porcine vascular endothelial cells. Collectively, placentae for lower birth weight neonates are vulnerable to oxidative damage, mitochondrial dysfunction, and impaired angiogenesis.